MSK Awards & Appointments

Share
Print

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:

Tsvi Gal Is Named MSK’s Head of Infrastructure

Tsvi Gal

Tsvi Gal

Tsvi Gal has been appointed Head of Infrastructure of MSK. Mr. Gal assumed his role on April 28. Mr. Gal will lead the hospital’s technological and architectural development and make technical recommendations that align with MSK’s institutional and digital priorities.

Reporting to MSK’s Chief Information Officer, Atefeh Riazi, Mr. Gal will work with other leaders in Digital Informatics and Technology Solutions to develop a modernized infrastructure and data environment in support of MSK’s digital strategy, set by MSK’s Chief Digital Officer Claus Jensen.


Marcel R. M. van den Brink

Marcel R.M. van den Brink, MD, PhD

Marcel van den Brink Is Elected to Royal Netherlands Academy of Arts and Sciences

Marcel R. M. van den Brink, MD, PhD, Head of the Division of Hematologic Malignancies and Alan N. Houghton Chair, has been elected to the Royal Netherlands Academy of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen, or KNAW). Dr. van den Brink is one of 18 new members to be elected to KNAW. Members consist of leading scientists across all disciplines and are chosen for their scientific achievements.


Scott Keeney, PhD and Christopher Lima, PhD

Scott Keeney, PhD and Christopher Lima, PhD

Scott Keeney and Christopher Lima Are Elected to National Academy of Sciences

Scott Keeney, PhD, a member of the Molecular Biology Program at Sloan Kettering Institute (SKI) and an Investigator of the Howard Hughes Medical Institute, and Christopher Lima, PhD, Chair of SKI’s Structural Biology Program and an Investigator of the Howard Hughes Medical Institute, have been elected to the National Academy of Sciences.

Dr. Keeney is being recognized for his quest to understand the mechanism of meiotic recombination and to determine how this process is coordinated with other events of meiotic prophase.

Dr. Lima is being recognized for his work on the structural, biochemical, and functional characterization of macromolecules involved in post-translational protein modification by ubiquitin and ubiquitin-like proteins such as SUMO, and the pathways that contribute to co- and post-transcriptional RNA maturation, processing, and decay.


Stuart Lichtman and Mark Robson Are Named 2020 Fellows of the American Society of Clinical Oncology

Stuart Lichtman, MD, FACP, FASCO, medical oncologist, and Mark Robson, MD, Chief of the Breast Medicine Service, were named a recipients of the Fellow of the American Society of Clinical Oncology (FASCO) distinction from the ASCO Special Awards. The FASCO recognizes ASCO members for their contributions to cancer care as well as their extraordinary volunteer service, dedication, and commitment to the Society.


Mithat Gönen, PhD

Mithat Gönen, PhD

Mithat Gönen Is Elected President-Elect to the Society for Clinical Trial’s Board of Directors

Mithat Gönen, PhD, Chief of the Biostatistics Service, was elected as President-Elect to the Board of Directors of the Society for Clinical Trials, a multidisciplinary society focusing on the methodology and conduct of clinical trials with membership spanning many disciplines including biostatistics, clinical areas, information technology and systems, data management, ethics, regulatory bodies, behavioral science, research coordination, patient partners, health outcomes research.

He will be President-Elect from May 2020 to May 2021; President from May 2021 to May 2022; and Past-President from May 2022 to May 2023. In this role, Dr. Gönen will be responsible for all aspects and decision-making involving the daily operations, short-term planning of activities and long-term strategic planning of the society.


David S. Klimstra, MD

David S. Klimstra, MD

David Klimstra Is Elected President of Pancreatobiliary Pathology Society

David Klimstra, MD, Chair of the Department of Pathology and James Ewing Alumni Chair of Pathology, was elected President of the Pancreatobiliary Pathology Society at the 2020 United States and Canadian Academy of Pathology Annual Meeting in February.


Laura Cerviño, PhD

Laura Cerviño, PhD

Laura Cerviño is Named 2020 Fellow of American Association of Physicists in Medicine

Laura Cerviño, PhD, Chief of the Radiotherapy Physics Service, was named a 2020 American Association of Physicists in Medicine (AAPM) Fellow. Dr. Cerviño was recognized for her contributions in medicine. 

She will be recognized at the upcoming joint AAPM/Canadian Organization of Medical Physicists virtual meeting in Vancouver on July 13, 2020.